LIFECELL CORPORATION

Address

LIFECELL CORPORATION
1 MILLENIUM WAY
SOMERVILLE, NJ, 08876

Information

DUNS:
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Biglycan as a Therapeutic for Muscular Dystrophy

    Amount: $1,100,816.00

    DESCRIPTION (provided by applicant): The overall goal of this proposal is to use animal models to test the efficacy of biglycan as a protein therapeutic for muscular dystrophy. Duchenne's muscular dys ...

    SBIRPhase II2003Department of Health and Human Services
  2. Biochemical Stabilization for Freeze Dried Platelets

    Amount: $98,050.00

    DESCRIPTION (provided by applicant): The focus of this Phase I proposal is to assess the feasibility of applying our platform of cellular biochemical stabilization with unique freezing and drying engi ...

    SBIRPhase I2003Department of Health and Human Services
  3. Gene Activated Cymetra for Repair of Orthopaedic Tissue

    Amount: $100,312.00

    DESCRIPTION (provided by applicant): The repair of damaged articular cartilage is problematic due to the limited regenerative potential of this tissue. Current procedures used for the repair of art ...

    SBIRPhase I2003Department of Health and Human Services
  4. BIGLYCAN AS A THERAPEUTIC FOR MUSCULAR DYSTROPHY

    Amount: $100,313.00

    DESCRIPTION (provided by applicant): The overall goal of this proposal is to use animal models to test the efficacy of biglycan as a protein therapeutic for muscular dystrophy. Duchenne's muscular dys ...

    SBIRPhase I2002Department of Health and Human Services
  5. N/A

    Amount: $100,000.00

    N/A

    SBIRPhase I2000Department of Health and Human Services
  6. Frozen Storage of Human Platelets with Directly Transfusable Cryoprotectants

    Amount: $69,852.00

    Not Available Mission Research Corporation (MRC) proposes to develop and demonstrate a solution to the single event effects (SEE) problems which result in data loss in deep submicron microcircuits us ...

    SBIRPhase I1999Army Department of Defense
  7. DirectlyTransfusable Cryopreserved Red Blood Cells

    Amount: $99,884.00

    This program is designed to establish the feasibility of developing a directly transfusable cryopreserved Red Blood cell (RBC) product. The approach of Lifecell's program is to utilize oxidative co ...

    SBIRPhase I1998Office of the Secretary of Defense Department of Defense
  8. RECONSTITUTED SKIN

    Amount: $300,000.00

    THE CURRENT ACCEPTED TREATMENT FOR REPLACING FULL-THICKNESS SKIN LOST TO INJURY OR ULCERATION IS TO GRAFT HEALTHY, SPLIT-THICKNESS SKIN (SSG) FROM AN UNINJURED AREA OF THE BODY TO THE WOUND SITE. TRE ...

    SBIRPhase II1996National Science Foundation
  9. RECONSTITUTED SKIN

    Amount: $65,000.00

    N/A

    SBIRPhase I1994National Science Foundation
  10. PROLONGED PRESERVATION OF HUMAN PLATELETS FOR COMBAT CASUALTY CARE

    Amount: $741,232.00

    THE AIM OF THIS PROPOSAL IS TO DEVELOP PROTOCOLS FOR THE LONG-TARTS CRYOPRESERVATION OF HUMAN PLATELETS FOR TRANSFUSION. OPTIMIZATION OF PLATELET ISOLATION AND CRYOPRESERVATION WILL BE COMBINED WITH S ...

    SBIRPhase II1993Army Department of Defense

Agency Micro-sites

US Flag An Official Website of the United States Government